Home NDC 72000-310 SIVEXTRO
Product NDC 72000-310
11-digit product format 720000310
Labeler code 72000
Product ID 72000-310_6b3f7c1e-f936-4651-9cfe-43f1634a00c9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name tedizolid phosphate
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Nabriva Therapeutics US, Inc.
Application NDA205435
Marketing category NDA
Marketing start 2014-06-20
Marketing end 0000-00-00
Substance TEDIZOLID PHOSPHATE
Active strength 200 mg/1
Pharmacologic classes Breast Cancer Resistance Protein Inhibitors [MoA], Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N205435-001 SIVEXTRO TEDIZOLID PHOSPHATE 200MG TABLET / ORAL RLD, RS 2014-06-20
Orange Book patents# Current patent rows page 1 of 1 · 7 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N205435-001 8420676 2028-02-23 U-282 Drug substance, Drug product 2014-07-03 N205435-001 7816379 2028-06-20 U-2507 Drug substance, Drug product 2014-07-03 N205435-001 10065947 2030-02-03 Drug product 2019-04-09 N205435-001 10442829 2030-02-03 Drug substance 2019-11-13 N205435-001 9624250 2030-02-03 U-2507 Drug substance, Drug product 2019-04-09 N205435-001 9988406 2030-02-03 Drug product 2019-04-09 N205435-001 8426389 2030-12-31 U-282 Drug substance, Drug product 2014-07-03
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N205435-001 NPP 2028-04-04
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 84e616aacf4f…2026-08-18 06:07:40 2026-07 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N205435-001 SIVEXTRO 200MG TABLET / ORAL RLD, RS 2014-06-20 f41ea6bd6efb…
Observed Orange Book patent history# Patent history page 1 of 8 · 298 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N205435-001 8420676 2028-02-23 U-282 Drug substance, Drug product 2014-07-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205435-001 7816379 2028-06-20 U-2507 Drug substance, Drug product 2014-07-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205435-001 10065947 2030-02-03 Drug product 2019-04-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205435-001 10442829 2030-02-03 Drug substance 2019-11-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205435-001 9624250 2030-02-03 U-2507 Drug substance, Drug product 2019-04-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205435-001 9988406 2030-02-03 Drug product 2019-04-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 N205435-001 8426389 2030-12-31 U-282 Drug substance, Drug product 2014-07-03 84e616aacf4f…2026-08-18 06:07:40 2026-07 N205435-001 8420676 2028-02-23 U-282 Drug substance, Drug product 2014-07-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205435-001 7816379 2028-06-20 U-2507 Drug substance, Drug product 2014-07-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205435-001 10065947 2030-02-03 Drug product 2019-04-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205435-001 10442829 2030-02-03 Drug substance 2019-11-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205435-001 9624250 2030-02-03 U-2507 Drug substance, Drug product 2019-04-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205435-001 9988406 2030-02-03 Drug product 2019-04-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N205435-001 8426389 2030-12-31 U-282 Drug substance, Drug product 2014-07-03 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N205435-001 8420676 2028-02-23 U-282 Drug substance, Drug product 2014-07-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205435-001 7816379 2028-06-20 U-2507 Drug substance, Drug product 2014-07-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205435-001 10065947 2030-02-03 Drug product 2019-04-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205435-001 10442829 2030-02-03 Drug substance 2019-11-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205435-001 9624250 2030-02-03 U-2507 Drug substance, Drug product 2019-04-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205435-001 9988406 2030-02-03 Drug product 2019-04-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205435-001 8426389 2030-12-31 U-282 Drug substance, Drug product 2014-07-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205435-001 8420676 2028-02-23 U-282 Drug substance, Drug product 2014-07-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205435-001 7816379 2028-06-20 U-2507 Drug substance, Drug product 2014-07-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205435-001 10065947 2030-02-03 Drug product 2019-04-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205435-001 10442829 2030-02-03 Drug substance 2019-11-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205435-001 9624250 2030-02-03 U-2507 Drug substance, Drug product 2019-04-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205435-001 9988406 2030-02-03 Drug product 2019-04-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205435-001 8426389 2030-12-31 U-282 Drug substance, Drug product 2014-07-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205435-001 8420676 2028-02-23 U-282 Drug substance, Drug product 2014-07-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205435-001 7816379 2028-06-20 U-2507 Drug substance, Drug product 2014-07-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205435-001 10065947 2030-02-03 Drug product 2019-04-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205435-001 10442829 2030-02-03 Drug substance 2019-11-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205435-001 9624250 2030-02-03 U-2507 Drug substance, Drug product 2019-04-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205435-001 9988406 2030-02-03 Drug product 2019-04-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205435-001 8426389 2030-12-31 U-282 Drug substance, Drug product 2014-07-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205435-001 8420676 2028-02-23 U-282 Drug substance, Drug product 2014-07-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205435-001 7816379 2028-06-20 U-2507 Drug substance, Drug product 2014-07-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205435-001 10065947 2030-02-03 Drug product 2019-04-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205435-001 10442829 2030-02-03 Drug substance 2019-11-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205435-001 9624250 2030-02-03 U-2507 Drug substance, Drug product 2019-04-09 fd3edfee7708…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 96 observed states.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 72000-310-06 SIVEXTRO 6 in 1 BLISTER PACK TABLET, FILM COATED 6 7 72000-310-06 SIVEXTRO 1 in 1 CARTON TABLET, FILM COATED 1 7 72000-310-30 SIVEXTRO 30 in 1 BOTTLE TABLET, FILM COATED 30 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72000-310 SIVEXTRO (TEDIZOLID PHOSPHATE) TABLET, FILM COATED SIVEXTRO (TEDIZOLID PHOSPHATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [NABRIVA THERAPEUTICS US, INC.] 7 Legacy NDC, 3 package rows 20241122_11d5c110-c48c-438f-9c7d-5adf99938534.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join SIVEXTRO TEDIZOLID PHOSPHATE Merck Sharp & Dohme LLC 75672079-589f-451a-bdbf-eaebcfcc80a9 2026-02-27 Warnings, Adverse reactions Exact identifier application applno (NDA): 205435 application number: NDA205435
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 72000-310-06 72000031006 1 BLISTER PACK in 1 CARTON (72000-310-06) > 6 TABLET, FILM COATED in 1 BLISTER PACK 1 blister pack 2014-06-20 0000-00-00 No No Current 72000-310-30 72000031030 30 TABLET, FILM COATED in 1 BOTTLE (72000-310-30) 2014-06-20 0000-00-00 No No Current